
Syndromic testing – the future of molecular diagnostics
Syndromic testing with the QIAstat-Dx system allows you to rapidly and simultaneously survey a large number of pathogens in a single sample. This means you can get comprehensive diagnostic answers in around an hour. And patients can get the right treatment faster.
To learn more about the benefits of QIAstat-Dx syndromic testing and hear about the latest insights on molecular diagnostics for infectious disease, watch our most recent webinars.
Watch the webinars
QIAstat-Dx resources and further reading
-
Go beyond fast resultsLearn how multiplex PCR testing offers a variety of benefits for healthcare institutions, including improved patient management and cost savings. -
Syndromic testing simplifiedSet your lab up for success with a streamlined syndromic test. The QIAstat-Dx panels redefine ease-of-use with less than one minute hands-on time and a seamless sample to result workflow. -
Get in touchContact the QIAGEN team to learn more about QIAstat-Dx syndromic testing or to place an order.
The QIAstat-Dx Analyzer and QIAstat-Dx Respiratory SARS-CoV-2 Panel are intended for in vitro diagnostic use.
Product availability and claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.